scispace - formally typeset
Search or ask a question
Institution

Aix-Marseille University

EducationMarseille, France
About: Aix-Marseille University is a education organization based out in Marseille, France. It is known for research contribution in the topics: Population & Galaxy. The organization has 24326 authors who have published 54240 publications receiving 1455416 citations. The organization is also known as: University Aix-Marseille & université d'Aix-Marseille.


Papers
More filters
Journal ArticleDOI
Peter A. R. Ade1, Nabila Aghanim2, Francisco Argüeso3, Monique Arnaud4  +305 moreInstitutions (77)
TL;DR: The Second Planck Catalogue of Compact Sources (PCCS2) as discussed by the authors is a list of discrete objects detected in single-frequency maps from the full duration of the Planck mission and supersedes previous versions.
Abstract: The Second Planck Catalogue of Compact Sources is a list of discrete objects detected in single-frequency maps from the full duration of the Planck mission and supersedes previous versions. It consists of compact sources, both Galactic and extragalactic, detected over the entire sky. Compact sources detected in the lower frequency channels are assigned to the PCCS2, while at higher frequencies they are assigned to one of two subcatalogues, the PCCS2 or PCCS2E, depending on their location on the sky. The first of these (PCCS2) covers most of the sky and allows the user to produce subsamples at higher reliabilities than the target 80% integral reliability of the catalogue. The second (PCCS2E) contains sources detected in sky regions where the diffuse emission makes it difficult to quantify the reliability of the detections. Both the PCCS2 and PCCS2E include polarization measurements, in the form of polarized flux densities, or upper limits, and orientation angles for all seven polarization-sensitive Planck channels. The improved data-processing of the full-mission maps and their reduced noise levels allow us to increase the number of objects in the catalogue, improving its completeness for the target 80% reliability as compared with the previous versions, the PCCS and the Early Release Compact Source Catalogue (ERCSC).

238 citations

Journal ArticleDOI
01 Jan 2007-Leukemia
TL;DR: Mylotarg administered in fractionated doses demonstrated an excellent efficacy/safety profile and a re-expression of CD33 antigenic sites on the cell surface of blasts cells after exposure to GO was observed.
Abstract: Pivotal phase II studies in acute myeloblastic leukemia (AML) patients in first relapse have used gemtuzumab ozogamicin (GO) (Mylotarg) at a dose of 9 mg/m(2) on days 1 and 14. These studies showed a 26% response rate (13% complete remission (CR) and 13% CRp (complete remission with incomplete platelet recovery)) but with high degree of hematological and liver toxicities. Based on in vitro studies showing a re-expression of CD33 antigenic sites on the cell surface of blasts cells after exposure to GO, we hypothesized that fractionated doses of GO may be efficient and better tolerated. Fifty-seven patients with AML in first relapse received GO at a dose of 3 mg/m(2) on days 1, 4 and 7 for one course. Fifteen patients (26%) achieved CR and four (7%) CRp. Remission rate correlated strongly with P-glycoprotein and MRP1 activities. The median relapse-free survival was 11 months, similar for CR or CRp patients. Median duration of neutropenia < 500/microl and thrombocytopenia < 50,000/microl were, respectively, 23 and 21 days. No grade 3 or 4 liver toxicity was observed. No veno-occlusive disease occurred after GO or after hematopoietic stem cell transplantation given after GO in seven patients. Mylotarg administered in fractionated doses demonstrated an excellent efficacy/safety profile.

238 citations

Journal ArticleDOI
TL;DR: The studies describing the associations between the microbiota composition, its manipulation, and obesity are reviewed to propose mechanisms linking the microbiota to fat content and weight.

237 citations

Journal ArticleDOI
Abulikemu Abudurexiti1, Scott Adkins2, Daniela Alioto3, S. V. Alkhovsky, Tatjana Avšič-Županc4, Matthew J. Ballinger5, Dennis A. Bente6, Martin Beer7, Eric Bergeron1, Carol D. Blair8, Thomas Briese9, Michael J. Buchmeier10, Felicity J. Burt11, Charles H. Calisher8, Chénchén Cháng12, Rémi N. Charrel13, Il-Ryong Choi14, J. Christopher S. Clegg, Juan Carlos de la Torre15, Xavier de Lamballerie13, Fēi Dèng, Francesco Di Serio, Michele Digiaro, Michael A. Drebot16, Xiǎoméi Duàn12, Hideki Ebihara17, Toufic Elbeaino, Koray Ergünay18, Charles F. Fulhorst6, Aura R. Garrison19, George Fú Gāo20, Jean-Paul Gonzalez21, Martin H. Groschup7, Stephan Günther22, Anne Lise Haenni23, Roy A. Hall24, Jussi Hepojoki25, Jussi Hepojoki26, Roger Hewson27, Zhìhóng Hú, Holly R. Hughes1, Miranda Gilda Jonson28, Sandra Junglen29, Boris Klempa30, Jonas Klingström31, Chūn Kòu12, Lies Laenen32, Amy J. Lambert1, Stanley A. Langevin33, Dan Liu34, Igor S. Lukashevich35, Tāo Luò1, Chuánwèi Lǚ, Piet Maes32, William Marciel de Souza36, Marco Marklewitz29, Giovanni P. Martelli37, Keita Matsuno38, Nicole Mielke-Ehret39, Maria Minutolo3, Ali Mirazimi40, Abulimiti Moming12, Hans Peter Mühlbach39, Rayapati A. Naidu41, Beatriz Navarro, Márcio Roberto Teixeira Nunes, Gustavo Palacios19, Anna Papa42, Alex Pauvolid-Corrêa43, Janusz T. Paweska, Jié Qiáo, Sheli R. Radoshitzky19, R. O. Resende44, Víctor Romanowski45, Amadou A. Sall46, Maria S. Salvato47, Takahide Sasaya48, Shū Shěn, Xiǎohóng Shí49, Yukio Shirako50, Peter Simmonds51, Manuela Sironi, Jin Won Song52, Jessica R. Spengler1, Mark D. Stenglein8, Zhèngyuán Sū, Sùróng Sūn12, Shuāng Táng, Massimo Turina53, Bó Wáng, Chéng Wáng1, Huálín Wáng, Jūn Wáng, Taiyun Wei54, Anna E. Whitfield55, F. Murilo Zerbini56, Jìngyuàn Zhāng12, Lěi Zhāng, Yànfāng Zhāng, Yong-Zhen Zhang57, Yong-Zhen Zhang20, Yújiāng Zhāng1, Xueping Zhou, Lìyǐng Zhū, Jens H. Kuhn58 
Centers for Disease Control and Prevention1, United States Department of Agriculture2, University of Naples Federico II3, University of Ljubljana4, Mississippi State University5, University of Texas Medical Branch6, Friedrich Loeffler Institute7, Colorado State University8, Columbia University9, University of California, Irvine10, University of the Free State11, Xinjiang University12, Aix-Marseille University13, International Rice Research Institute14, Scripps Research Institute15, Public Health Agency of Canada16, Mayo Clinic17, Hacettepe University18, United States Army Medical Research Institute of Infectious Diseases19, Chinese Center for Disease Control and Prevention20, Kansas State University21, Bernhard Nocht Institute for Tropical Medicine22, Paris Diderot University23, University of Queensland24, University of Zurich25, University of Helsinki26, Public Health England27, Seoul National University28, Charité29, Slovak Academy of Sciences30, Karolinska Institutet31, Katholieke Universiteit Leuven32, University of Washington33, Wuhan University of Science and Technology34, University of Louisville35, University of São Paulo36, University of Bari37, Hokkaido University38, University of Hamburg39, Public Health Agency of Sweden40, Washington State University41, Aristotle University of Thessaloniki42, Oswaldo Cruz Foundation43, University of Brasília44, National University of La Plata45, Pasteur Institute46, University of Maryland, Baltimore47, National Agriculture and Food Research Organization48, University of Glasgow49, University of Tokyo50, University of Oxford51, Korea University52, National Research Council53, Fujian Agriculture and Forestry University54, North Carolina State University55, Universidade Federal de Viçosa56, Fudan University57, National Institutes of Health58
TL;DR: The updated taxonomy of the order Bunyavirales now accepted by the International Committee on Taxonomy of Viruses (ICTV) is presented.
Abstract: In February 2019, following the annual taxon ratification vote, the order Bunyavirales was amended by creation of two new families, four new subfamilies, 11 new genera and 77 new species, merging of two species, and deletion of one species. This article presents the updated taxonomy of the order Bunyavirales now accepted by the International Committee on Taxonomy of Viruses (ICTV).

237 citations

Journal ArticleDOI
TL;DR: In this paper, the authors explore the evolution of the star formation activity and dust attenuation properties of star-forming galaxies up to z~4, using mass-complete samples.
Abstract: We use the deep panchromatic dataset available in the GOODS-N field, spanning all the way from GALEX ultra-violet to VLA radio continuum data, to select a star-forming galaxy sample at z~[0.5-4] and robustly measure galaxy photometric redshifts, star formation rates, stellar masses and UV rest-frame properties. We quantitatively explore, using mass-complete samples, the evolution of the star formation activity and dust attenuation properties of star-forming galaxies up to z~4. Our main results can be summarized as follows: i) we find that the slope of the SFR-M correlation is consistent with being constant, and equal to ~0.8 at least up to z~1.5, while the normalization keeps increasing to the highest redshift, z~4, we are able to explore; ii) for the first time in this work, we are able to explore the FIR-radio correlation for a mass-selected sample of star-forming galaxies: the correlation does not evolve up to z~4; iii) we confirm that galaxy stellar mass is a robust proxy for UV dust attenuation in star-forming galaxies, with more massive galaxies being more dust attenuated; iv) strikingly, we find that this attenuation relation evolves very weakly with redshift, the amount of dust attenuation increasing by less than 0.3 magnitudes over the redshift range [0.5-4] for a fixed stellar mass, as opposed to a tenfold increase of star formation rate; v) this finding explains the evolution of the SFR-Auv relation reported in literature: the same amount of star formation is less attenuated at higher redshift because it is hosted in less massive, and less metal rich, galaxies; vi) the correlation between dust attenuation and the UV spectral slope evolves in redshift, with the median UV spectral slope of star-forming galaxies becoming bluer with redshift. By z~3, typical UV slopes are inconsistent, given the measured dust attenuation, with the predictions of commonly used empirical laws: this means that the present cosmic star formation rate density estimates at redshift z > 3 need to be increased by a factor of around 2. Finally, building on the measured AUV–logM correlation and on existing results, we find evidence that line reddening is marginally larger (by a factor of around 1.3) than continuum reddening at all redshifts probed, and also that the amount of dust attenuation at a fixed ISM metallicity increases with redshift. We speculate that our results point toward an evolution of the ISM conditions of the median star-forming galaxy, such that at z >1.5, Main Sequence galaxies have ISM properties more similar to those found in local starbursts.

237 citations


Authors

Showing all 24784 results

NameH-indexPapersCitations
Didier Raoult1733267153016
Andrea Bocci1722402176461
Marc Humbert1491184100577
Carlo Rovelli1461502103550
Marc Besancon1431799106869
Jian Yang1421818111166
Josh Moss139101989255
Maksym Titov1391573128335
Bernard Henrissat139593100002
R. D. Kass1381920107907
Stylianos E. Antonarakis13874693605
Jean-Paul Kneib13880589287
Brad Abbott137156698604
Shu Li136100178390
Georges Aad135112188811
Network Information
Related Institutions (5)
University of Paris
174.1K papers, 5M citations

96% related

Pierre-and-Marie-Curie University
56.1K papers, 2.3M citations

94% related

Centre national de la recherche scientifique
382.4K papers, 13.6M citations

94% related

University of Geneva
65.2K papers, 2.9M citations

94% related

University of California, San Diego
204.5K papers, 12.3M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023170
2022748
20215,607
20205,697
20195,288
20185,125